NCT04902573Completed
A Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes
A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes
Source: ClinicalTrials.gov · Last updated 11 Sept 2025
Brief summary (registry, in English)
TriMaximize, a non-interventional trial aims to collect prospective, longitudinal data from asthma patients under routine care, for whom their treating physician has decided to prescribe Trimbow® (beclometasone/formoterol/glycopyrronium).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 147 (actual)
- First submitted
- 17 May 2021
- Start date
- 17 Jun 2021
- Primary completion date
- 14 Jun 2024
- Lead sponsor
- Chiesi UK
- Diseases
- Asthma
- NCT number
- NCT04902573
What you commit to
- Study type: Observational
- Participants enrolled: 147
- From 17 Jun 2021 to the primary completion date, 14 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\) Participation in an interventional clinical trial within 30 days prior to enrolment into the present non-interventional study or planned enrolment in an interventional clinical trial during the observational period.
Who the study is looking for
- Patients ≥ 18 years of age,
- Patients with confirmed leading diagnosis of asthma with or without concomitant COPD,
- Physician decision to start fixed triple therapy with ICS/LABA/LAMA (Trimbow MS or HS) according to its current authorised indication. The treatment decision must be made independently from participation in this NIS,
- Patients willing and able to sign an informed consent for use of their pseudonymised clinical data within the present non-interventional study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Haven Surgery, The Haven, Burnhope, Coordinator of this site? Confirm its status | Durham | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.